Olive Garden is introducing another way for guests to enjoy its iconic breadsticks with a new menu offering – Signature Breadstick Bun Sandwiches served with fries and choice of unlimited homemade soup or Famous House Salad. Beginning today, guests can satisfy their lunchtime cravings with one of two Breadstick Bun Sandwiches, starting at just $6.99.
The much-anticipated Signature Breadstick Bun Sandwiches have been making headlines with fans across the nation looking forward to their first taste. That’s why Olive Garden is inviting guests to celebrate the new menu offering throughout the summer with Breadstick Nation – a seven-week-long nationwide tour of four Olive Garden food trucks that will be giving away free samples of the Signature Breadstick Bun Sandwiches. The tour will hit the road today with one food truck in New York City and will be joined by additional trucks visiting 20 cities nationwide.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7303851-olive-garden-breadstick-bun-sandwiches/
Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its presence at the American Association for Clinical Chemistry (AACC) 2016 Clinical Lab Expo today by featuring several next-generation diagnostic testing platforms and a new virtual reality experience that gives attendees an “under the hood” look at a lab of the future and an innovative concept Roche calls the “Roche connected lab.”
The virtual reality theater will enable attendees to view samples moving through a virtual lab equipped with various configurations of Roche automation, chemistry/immunoassay platforms and molecular diagnostics systems, as well as connections to third-party platforms. The actual Roche systems that are part of the connected lab concept will also be on display in the booth.
To view the multimedia release go to:
http://www.multivu.com/players/English/7889151-roche-aacc-2016/
The Yankee Candle Company, Inc., the world’s largest manufacturer of premium scented candles, today announced the launch of two new fragrances and the return of three favorites in its popular limited edition Man Candles collection. Just in time for Father’s Day, Camouflage and On Tap™ join last year’s introduction MMM, Bacon!™ and original Man Candles Man Town™ and Riding Mower™. The Man Candles collection, which was an instant hit when it debuted in 2012, was created uniquely for men to enjoy in their “man town,” wherever that may be in the house. These limited edition fragrances are available now at Yankee Candle’s over 500 retail stores, at www.yankeecandle.com and select specialty retailers and gift shops. Yankee Candle is launching a series of social media contests offering consumers the chance to win samples of the Man Candles III collection!
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7221651-yankee-candle-heads-outdoors-new-man-candles-fragrances
Texas Instruments (TI) (NASDAQ: TXN) today introduced five new next-generation power management integrated circuits that efficiently acquire and manage microwatts (uW) to milliwatts (mW) of power harvested from light, heat or mechanical energy sources. The bq25570, bq25505, TPS62740, TPS62737 and TPS62736 maintain the industry’s lowest levels of active quiescent current and enable battery-free operation to wireless sensor networks, monitoring systems, wearable medical devices, mobile accessories and other applications with limited access to power. To order samples and development kits, visit: www.ti.com/energyharvesting-pr.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/54051-texas-instruments-next-wave-of-energy-harvesting-design
In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.
St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature.
“Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
http://www.bigcitiloops.com/genres/1/hip-hop-loops offers everything from hip hop drum loops to free hip hop samples. Huge collection of hip hop sample packs to fit every taste and every occasion.
Today on Rare Disease Day, My Life, Our Future, a national program founded by leaders in the bleeding disorder community, including Bloodworks Northwest, the American Thrombosis and Hemostasis Network, the National Hemophilia Foundation and Bioverativ Inc., opened the largest research repository of its kind in the world to scientists. The My Life, Our Future Research Repository is a collection of genetic data and blood samples that are linked to phenotypic data from more than 5,000 people in the U.S. with hemophilia, a rare disorder that impairs the ability of one’s blood to clot. The My Life, Our Future Research Repository will allow researchers to advance the scientific understanding of the disorder, including genetic differences that affect bleeding severity and reaction to certain treatments.
To view the multimedia release go to:
https://www.multivu.com/players/English/8046151-national-hemophilia-foundation-my-life-our-future/
Pathology isn’t just slides and stains — it’s the words that make those findings usable. MTS pathology transcription services capture specimen details, findings, and diagnosis with speed and structure, so reports move cleanly into care. HIPAA safeguards, specialty-trained transcriptionists, and fast turnarounds mean fewer delays and clearer decisions. When documentation reads right, treatment moves right.
